Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 112
interventional 95
Observational 15
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 37
Drug|placebo 12
Drug|Radiation 9
Biological 8
Radiation 4
Procedure 3
Device 2
Drug|Other 2
Drug|Other|placebo 2
Other 2
Behavioral 1
Biological|Drug 1
Biological|Drug|Radiation 1
Biological|placebo 1
Combination Product|Drug 1
Device|Drug 1
Device|Drug|Procedure 1
Device|Drug|Radiation 1
Dietary Supplement 1
Drug|placebo|Procedure 1
Drug|Procedure 1
Genetic 1
Other|Procedure 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
China 24
United States 21
Canada 5
Hong Kong 5
NA 5
Netherlands 3
United States|Canada 3
Belgium 2
Singapore 2
United Kingdom 2
United States|Puerto Rico 2
Algeria|Brazil|China|France|India|Indonesia|Italy|Korea, Republic of|Mexico|Morocco|Philippines|Thailand|Tunisia|Turkey 1
Belgium|Germany 1
Canada|United States|Austria|Belgium|Denmark|Germany|Hungary|Poland 1
China|Taiwan|Thailand 1
Czechia|France|Israel|Italy|Netherlands|Spain 1
Hong Kong|Indonesia|Malaysia|Taiwan|Thailand 1
Hong Kong|Singapore 1
Korea, Republic of 1
Morocco 1
Norway 1
Puerto Rico 1
Russian Federation 1
Spain 1
Taiwan 1
United States|Belgium 1
United States|Belgium|Canada|Germany|Netherlands|Spain|United Kingdom 1
United States|Belgium|Germany|Netherlands|Spain|United Kingdom 1
United States|Canada|France|Germany|Israel|Netherlands|Poland|Puerto Rico|Spain|Sweden 1
United States|Canada|France|Greece|Italy|Singapore|Spain|Taiwan|Tunisia 1
United States|China|France|Hong Kong|Singapore 1
United States|South Africa 1

Sites per Study

Site_count Study_Count
1 62
2 7
3 1
4 1
5 3
6 2
8 2
9 3
11 1
13 1
15 1
17 2
18 1
25 1
26 1
29 1
33 1
35 1
42 1
98 1
108 1

Phase

Phase Study_Count
Phase 2 42
N/A 14
Phase 1 14
Phase 3 14
Phase 1/Phase 2 8
Phase 2/Phase 3 2
Phase 4 1

Number of Arms

Number_of_Arms Count_of_Studies
1 35
2 38
3 9
4 6
NA 7

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 12.0000 5.00000 20.0 4.00000 37.00 23.0000 114
1st Qu. 33.2500 19.00000 25.0 30.00000 42.25 155.2500 114
Median 81.5000 24.50000 28.0 46.00000 47.50 244.5000 114
Mean 102.9286 38.28571 39.5 60.19512 47.50 256.5714 114
3rd Qu. 137.7500 49.75000 60.0 72.00000 52.75 396.0000 114
Max. 386.0000 100.00000 70.0 263.00000 58.00 468.0000 114

Trial Group Type

group_type Group_Count
Experimental 103
Active Comparator 30
Placebo Comparator 17
NA 7
No Intervention 6
Other 6

Intervention Model

intervention_model Study_Count
Parallel Assignment 49
Single Group Assignment 42
NA 3
Sequential Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 81
Prevention 6
Diagnostic 3
Supportive Care 3
Basic Science 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
China 3
United States 3
Australia 2
NA 2
Belgium 1
Italy 1
Singapore 1
Taiwan 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 13
6 1
15 1

Enrollment Metrics

Measure Observational
Min 17.0000
1st Qu 92.5000
Median 166.0000
Mean 629.9333
3rd Qu 519.5000
Max 3795.0000

Observation Model

observational_model Study_Count
Cohort 10
Case-Only 2
Case Control 1
Family-Based 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 13
Retrospective 2

Registries

Studies by Country

Country Study_Count
Denmark 1
United States 1

Sites per Study

Site_count Study_Count
1 1
75 1

Enrollment Metrics

Measure Registries
Min 36.0
1st Qu 250026.8
Median 500017.5
Mean 500017.5
3rd Qu 750008.2
Max 999999.0

Registry Model

observational_model Study_Count
Cohort 2

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
1 Year 1
80 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03682055 Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT03682055 Active, not recruiting Cullinan Oncology, LLC 2021-10-31
NCT03401229 Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis https://ClinicalTrials.gov/show/NCT03401229 Active, not recruiting AstraZeneca 2020-08-07
NCT03323866 Mometasone vs Budesonide in CRS With Polyposis https://ClinicalTrials.gov/show/NCT03323866 Recruiting Université de Sherbrooke 2020-10-31
NCT03282617 Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03282617 Recruiting National University Hospital, Singapore 2019-08-14
NCT03196869 the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT03196869 Recruiting Guiyang Medical University 2019-04-12
NCT03175939 Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03175939 Completed Sun Yat-sen University 2008-12-31
NCT03144661 An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies https://ClinicalTrials.gov/show/NCT03144661 Recruiting Incyte Corporation 2021-02-28
NCT03129412 Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions https://ClinicalTrials.gov/show/NCT03129412 Recruiting Zhejiang Cancer Hospital 2023-04-23
NCT03096808 Adaptive Radiotherapy for Head and Neck Cancer https://ClinicalTrials.gov/show/NCT03096808 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-03-15
NCT03095703 Sirolimus and Familial Adenomatous Polyposis (FAP) https://ClinicalTrials.gov/show/NCT03095703 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2018-12-10
NCT03082534 Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT03082534 Recruiting University of California, San Diego 2019-12-30
NCT03010813 A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery https://ClinicalTrials.gov/show/NCT03010813 Completed Chinese University of Hong Kong 2017-10-31
NCT03007836 High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT03007836 Completed Fuda Cancer Hospital, Guangzhou 2017-12-01
NCT02961374 Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer https://ClinicalTrials.gov/show/NCT02961374 Active, not recruiting National Cancer Institute (NCI) 2020-02-23
NCT02915445 EpCAM CAR-T for Treatment of Nasopharyngeal Carcinoma and Breast Cancer https://ClinicalTrials.gov/show/NCT02915445 Recruiting Sichuan University 2020-07-31
NCT02902432 A Trial of Endostar in Patients With Carcinoma of the Head and Neck https://ClinicalTrials.gov/show/NCT02902432 Active, not recruiting China International Medical Foundation 2017-12-20
NCT02874651 ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy https://ClinicalTrials.gov/show/NCT02874651 Recruiting Sun Yat-sen University 2021-06-30
NCT02784262 Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis https://ClinicalTrials.gov/show/NCT02784262 Completed Norwegian University of Science and Technology 2018-09-04
NCT02734849 Study to Evaluate Multiple Doses in Patients With Nasal Polyposis https://ClinicalTrials.gov/show/NCT02734849 Completed Allakos, Inc. 2018-01-31
NCT02627807 Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02627807 Active, not recruiting Sun Yat-sen University 2020-12-31
NCT02611960 Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122) https://ClinicalTrials.gov/show/NCT02611960 Active, not recruiting Merck Sharp & Dohme Corp. 2020-11-30
NCT02608073 A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT02608073 Completed Hoffmann-La Roche 2009-11-30
NCT02592603 Endocuff for Surveillance of Serrated Polyposis Syndrome https://ClinicalTrials.gov/show/NCT02592603 Completed Hospital Clinic of Barcelona 2017-07-31
NCT02562924 The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery https://ClinicalTrials.gov/show/NCT02562924 Completed University of Vermont Medical Center 2017-12-31
NCT02507154 Reactivating NK Cells in Treating Refractory Head and Neck Cancer https://ClinicalTrials.gov/show/NCT02507154 Recruiting National University Hospital, Singapore 2019-08-31
NCT02456506 Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma. https://ClinicalTrials.gov/show/NCT02456506 Active, not recruiting Sun Yat-sen University 2022-12-31
NCT02444949 A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02444949 Completed China Three Gorges University, Yichang, China 2016-12-31
NCT02360501 Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02360501 Completed Sun Yat-sen University 2016-03-31
NCT02269943 Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02269943 Completed Celgene 2017-04-20
NCT02113878 Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck https://ClinicalTrials.gov/show/NCT02113878 Active, not recruiting Dana-Farber Cancer Institute 2020-12-31
NCT02113423 Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02113423 Completed Fujian Cancer Hospital 2009-06-30
NCT02113202 Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW https://ClinicalTrials.gov/show/NCT02113202 Completed University Medical Center Groningen 2015-10-31
NCT03353467 Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03353467 Recruiting Sun Yat-sen University 2020-10-01
NCT01937793 Swallowing Exercises for Nasopharyngeal Cancer After Radiation Therapy https://ClinicalTrials.gov/show/NCT01937793 Completed National Taiwan University Hospital 2013-12-31
NCT01806675 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy https://ClinicalTrials.gov/show/NCT01806675 Completed Stanford University 2016-12-07
NCT01800071 A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01800071 Completed Cancer Research UK 2017-03-10
NCT01797900 The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT https://ClinicalTrials.gov/show/NCT01797900 Completed Chinese Academy of Medical Sciences 2014-09-30
NCT01622569 Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety https://ClinicalTrials.gov/show/NCT01622569 Completed Optinose US Inc. 2015-08-06
NCT01483144 Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) https://ClinicalTrials.gov/show/NCT01483144 Completed Cancer Prevention Pharmaceuticals, Inc. 2018-11-30
NCT01469429 Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. https://ClinicalTrials.gov/show/NCT01469429 Completed Ohio State University Comprehensive Cancer Center 2014-09-17
NCT01393340 Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma https://ClinicalTrials.gov/show/NCT01393340 Completed University Hospital, Ghent 2008-10-31
NCT04230499 Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance https://ClinicalTrials.gov/show/NCT04230499 Recruiting Rapamycin Holdings Inc. 2022-06-30
NCT04094675 Sirolimus for Cowden Syndrome With Colon Polyposis https://ClinicalTrials.gov/show/NCT04094675 Recruiting Ohio State University 2021-12-31
NCT03924986 Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT03924986 Recruiting BeiGene 2021-08-31
NCT03890185 Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC https://ClinicalTrials.gov/show/NCT03890185 Active, not recruiting King Faisal Specialist Hospital & Research Center 2020-12-31
NCT03854838 IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. https://ClinicalTrials.gov/show/NCT03854838 Recruiting Sun Yat-sen University 2020-06-30
NCT03847532 MUTYH-associated Polyposis https://ClinicalTrials.gov/show/NCT03847532 Recruiting State Scientific Centre of Coloproctology, Russian Federation 2020-10-10
NCT03840421 GP vs PF as Induction Chemotherapy Combined With CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03840421 Recruiting Sun Yat-sen University 2023-02-14
NCT03837808 Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03837808 Recruiting Sun Yat-sen University 2022-02-11
NCT03806426 Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis https://ClinicalTrials.gov/show/NCT03806426 Recruiting S.L.A. Pharma AG 2021-03-01
NCT03769467 Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) https://ClinicalTrials.gov/show/NCT03769467 Recruiting Atara Biotherapeutics 2023-09-30
NCT03734809 NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT03734809 Recruiting Chinese University of Hong Kong 2022-12-31
NCT03700476 Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03700476 Recruiting Sun Yat-sen University 2023-01-31
NCT03688555 A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis https://ClinicalTrials.gov/show/NCT03688555 Active, not recruiting Idorsia Pharmaceuticals Ltd. 2020-11-30
NCT03687515 Efficacy and Safety of Budesonide Inhalation Suspension for the Treatment of Chronic Rhinosinusitis With Polyposis. https://ClinicalTrials.gov/show/NCT03687515 Completed Beijing Tongren Hospital 2016-12-03
NCT03649971 A Study of Guselkumab in Participants With Familial Adenomatous Polyposis https://ClinicalTrials.gov/show/NCT03649971 Recruiting Janssen Research & Development, LLC 2020-09-30
NCT03427827 Camrelizumab (PD-1 Antibody) After Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma (PACIFIC-NPC) https://ClinicalTrials.gov/show/NCT03427827 Recruiting Sun Yat-sen University 2022-02-28
NCT01256853 Modified Vaccinia Ankara (MVA) Vaccine Study https://ClinicalTrials.gov/show/NCT01256853 Completed Chinese University of Hong Kong 2010-09-30
NCT01197612 Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis https://ClinicalTrials.gov/show/NCT01197612 Completed University of Michigan 2012-06-30
NCT01187901 A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients https://ClinicalTrials.gov/show/NCT01187901 Completed University of Utah 2014-06-30
NCT01094405 Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy https://ClinicalTrials.gov/show/NCT01094405 Active, not recruiting Chinese University of Hong Kong 2021-12-31
NCT00982449 124I-FIAU Imaging in EBV and KSHV Associated Cancers https://ClinicalTrials.gov/show/NCT00982449 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2013-07-31
NCT00927485 Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP) https://ClinicalTrials.gov/show/NCT00927485 Completed University of Puerto Rico 2016-11-30
NCT04296851 Niclosamide for Familial Adenomatous Polyposis https://ClinicalTrials.gov/show/NCT04296851 Recruiting Yonsei University 2022-12-31
NCT02948699 A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT02948699 Active, not recruiting Zhejiang Cancer Hospital 2018-11-30
NCT00808743 Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis https://ClinicalTrials.gov/show/NCT00808743 Completed Radboud University 2011-07-31
NCT03791944 3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03791944 Recruiting Xinqiao Hospital of Chongqing 2019-01-31
NCT00770991 Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP) https://ClinicalTrials.gov/show/NCT00770991 Completed The Cleveland Clinic 2008-09-30
NCT00747799 Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT00747799 Completed Sun Yat-sen University 2011-05-31
NCT00706316 Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal Cancer https://ClinicalTrials.gov/show/NCT00706316 Completed University Health Network, Toronto 2009-08-31
NCT00697619 To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00697619 Completed Sun Yat-sen University 2009-01-31
NCT00641147 Curcumin in Treating Patients With Familial Adenomatous Polyposis https://ClinicalTrials.gov/show/NCT00641147 Completed National Cancer Institute (NCI) 2016-11-30
NCT00630149 Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy https://ClinicalTrials.gov/show/NCT00630149 Completed Sun Yat-sen University 2011-11-30
NCT00609219 T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC https://ClinicalTrials.gov/show/NCT00609219 Completed Baylor College of Medicine 2007-10-31
NCT00603915 A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00603915 Completed University Health Network, Toronto 2010-12-31
NCT00565448 Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents https://ClinicalTrials.gov/show/NCT00565448 Completed Sanofi 2009-03-31
NCT00525655 Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP) https://ClinicalTrials.gov/show/NCT00525655 Active, not recruiting M.D. Anderson Cancer Center 2020-02-28
NCT00510692 Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA https://ClinicalTrials.gov/show/NCT00510692 Completed S.L.A. Pharma AG 2008-04-30
NCT00480298 Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis https://ClinicalTrials.gov/show/NCT00480298 Completed University Hospital, Ghent NA
NCT00439426 A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. https://ClinicalTrials.gov/show/NCT00439426 Completed Hoffmann-La Roche 2009-09-30
NCT00436800 Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00436800 Completed Sanofi 2008-10-31
NCT00436293 Taxotere + Cisplatin in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00436293 Completed Sanofi 2010-03-31
NCT00430378 Acupuncture for Prevention of Radiation-Induced Xerostomia https://ClinicalTrials.gov/show/NCT00430378 Active, not recruiting M.D. Anderson Cancer Center 2021-01-31
NCT00408694 Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00408694 Completed National Cancer Institute (NCI) 2011-12-15
NCT00370890 A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy https://ClinicalTrials.gov/show/NCT00370890 Active, not recruiting Chinese University of Hong Kong 2020-12-31
NCT00305734 Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00305734 Completed National Cancer Institute (NCI) 2007-07-31
NCT00188877 Intensity Modulated Radiation Therapy for Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00188877 Completed University Health Network, Toronto 2008-06-30
NCT00141765 Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers https://ClinicalTrials.gov/show/NCT00141765 Completed University of Michigan Rogel Cancer Center 2008-12-31
NCT00123864 Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function https://ClinicalTrials.gov/show/NCT00123864 Completed AHS Cancer Control Alberta NA
NCT00101270 Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00101270 Completed National Cancer Institute (NCI) 2007-09-30
NCT00091182 Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment https://ClinicalTrials.gov/show/NCT00091182 Completed National Cancer Institute (NCI) 2006-02-28
NCT00003206 Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00003206 Completed Eastern Cooperative Oncology Group 2001-07-31
NCT00078546 EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT00078546 Completed Baylor College of Medicine 2007-01-31
NCT00078494 Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00078494 Completed National Institutes of Health Clinical Center (CC) NA
NCT00057785 Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00057785 Completed Radiation Therapy Oncology Group 2007-02-28

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03003182 A Study of Nasopharyngeal Carcinoma From Guangdong https://ClinicalTrials.gov/show/NCT03003182 Recruiting Sun Yat-sen University 2019-05-31
NCT02747862 Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance Program https://ClinicalTrials.gov/show/NCT02747862 Recruiting M.D. Anderson Cancer Center 2020-02-29
NCT02505139 The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients https://ClinicalTrials.gov/show/NCT02505139 Completed Sun Yat-sen University 2016-07-31
NCT02371135 Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes https://ClinicalTrials.gov/show/NCT02371135 Recruiting Memorial Sloan Kettering Cancer Center 2021-02-28
NCT02211677 Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02211677 Recruiting Sun Yat-sen University 2019-12-31
NCT02149641 Parotid-sparing IMRT for Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT02149641 Completed Royal Marsden NHS Foundation Trust 2011-04-30
NCT01604564 Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients https://ClinicalTrials.gov/show/NCT01604564 Active, not recruiting Universitaire Ziekenhuizen Leuven 2019-12-31
NCT01379872 Assessment of New Radiation Oncology Technologies and Treatments https://ClinicalTrials.gov/show/NCT01379872 Completed Trans-Tasman Radiation Oncology Group (TROG) 2012-05-31
NCT03670342 Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT03670342 Completed National Cancer Centre, Singapore 2019-04-15
NCT03471403 Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis https://ClinicalTrials.gov/show/NCT03471403 Recruiting Western Sydney Local Health District 2020-10-10
NCT03450889 Personalized Surveillance Protocol for Serrated Polyposis Syndrome https://ClinicalTrials.gov/show/NCT03450889 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2018-04-13
NCT03448341 Clinical and Instrumental Evaluation of Late Dysphagia in Patients With Oropharynx and Nasopharynx Cancer, Candidates to Combined Radiochemotherapy With Intensity Modulated Technique (IMRT) https://ClinicalTrials.gov/show/NCT03448341 Recruiting Azienda Ospedaliero, Universitaria Pisana 2022-07-16
NCT03656250 Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI https://ClinicalTrials.gov/show/NCT03656250 Completed NYU Langone Health 2018-11-19
NCT00342147 Family Study of Head and Neck Cancers in Taiwan https://ClinicalTrials.gov/show/NCT00342147 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT00173836 Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount https://ClinicalTrials.gov/show/NCT00173836 Completed National Taiwan University Hospital 2006-08-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02012699 Integrated Cancer Repository for Cancer Research https://ClinicalTrials.gov/show/NCT02012699 Recruiting University of Nebraska 2099-12-31
NCT03346980 Endoscopic Evaluation of Duodenal Polyposis in Patients With Familial Adenomatous Polyposis (FAP) https://ClinicalTrials.gov/show/NCT03346980 Completed Copenhagen University Hospital, Hvidovre 2020-01-23